Cefonicid vs. cefoxitin for cesarean section prophylaxis

Area of Science:

• Obstetrics and Gynecology
• Infectious Disease Prevention
• Pharmacology

Background:

• Cesarean section prophylaxis is crucial for preventing postpartum infections.
• Second-generation cephalosporins are commonly used for surgical prophylaxis.
• Comparing long-acting versus short-acting agents is important for optimizing treatment regimens.

Purpose of the Study:

• To compare the efficacy and safety of cefonicid (long-acting) versus cefoxitin (short-acting) for cesarean section prophylaxis.
• To evaluate the incidence of endometritis and febrile morbidity in patients receiving either antibiotic.

Main Methods:

• A randomized, prospective study involving 139 patients undergoing cesarean section.
• Group 1 received a single 1-g intravenous dose of cefonicid post-cord clamping.
• Group 2 received a 2-g intravenous dose of cefoxitin post-cord clamping and at 6, 12, and 18 hours postpartum.

Main Results:

• Endometritis incidence was 17.3% with cefonicid vs. 12.1% with cefoxitin (P > .397).
• Febrile morbidity incidence was 23.5% with cefonicid vs. 15.5% with cefoxitin (P > .25).
• No statistically significant differences were observed between the two antibiotic regimens.

Conclusions:

• Both cefonicid and cefoxitin demonstrate comparable efficacy in preventing postpartum infections following cesarean delivery.
• Cefonicid offers a potentially more cost-effective option due to its dosing schedule and lower price.
• Further economic analysis may support cefonicid as a preferred agent for cesarean prophylaxis.